MedTrace Logo

Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial

NCT07130682 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2026-03-16

No results posted yet for this study

Summary

This study is testing a shorter treatment method for prostate cancer using proton therapy (PT), which is very precise and may cause fewer side effects compared to traditional radiation. However, it is expensive and not easily accessible for many patients. To make it more affordable and accessible, this study is testing whether 2 fractions of stereotactic body proton therapy (SBPT) can be as safe and effective as the standard 5 sessions.

Conditions

  • Prostate Cancer Patients Treated by Radiotherapy

Interventions

RADIATION

Pencil Beam Proton Therapy Treatment Machine

2 fractions will be delivered to treat low- or intermediate- risk prostate cancer

Sponsors & Collaborators

  • Hong Kong Sanatorium & Hospital

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2033-01-02
Completion
2033-06-02

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07130682 on ClinicalTrials.gov